BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 03, 15:49Prev. Close
11.44
Open Price
11.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.59 (427)
Balance Sheet of Vaishali Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 10.55 | 6.59 | 6.59 | 3.00 | 0.50 | |
Total Share Capital | 10.55 | 6.59 | 6.59 | 3.00 | 0.50 | |
Reserves and Surplus | 10.84 | 14.81 | 14.01 | 0.97 | 2.70 | |
Total Reserves and Surplus | 10.84 | 14.81 | 14.01 | 0.97 | 2.70 | |
Total Shareholders Funds | 21.38 | 21.40 | 20.60 | 3.97 | 3.20 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 4.27 | 4.78 | 2.65 | 3.37 | 4.48 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | |
Long Term Provisions | 0.14 | 0.09 | 0.18 | 0.20 | 0.00 | |
Total Non-Current Liabilities | 4.41 | 4.87 | 2.83 | 3.57 | 4.65 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 11.82 | 11.45 | 14.91 | 17.75 | 15.29 | |
Trade Payables | 21.73 | 24.53 | 22.38 | 15.38 | 24.66 | |
Other Current Liabilities | 6.85 | 6.49 | 3.48 | 4.18 | 1.30 | |
Short Term Provisions | 0.01 | 0.01 | 0.01 | 0.01 | 0.31 | |
Total Current Liabilities | 40.42 | 42.48 | 40.79 | 37.32 | 41.55 | |
Total Capital And Liabilities | 66.20 | 68.75 | 64.22 | 44.87 | 49.41 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 0.78 | 0.88 | 0.98 | 1.14 | 1.40 | |
Intangible Assets | 0.71 | 0.46 | 0.28 | 0.15 | 0.00 | |
Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1.57 | 1.37 | 1.35 | 1.29 | 1.40 | |
Non-Current Investments | 0.43 | 0.43 | 0.43 | 0.38 | 0.38 | |
Deferred Tax Assets [Net] | 0.12 | 0.11 | 0.12 | 0.14 | 0.01 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | |
Other Non-Current Assets | 2.78 | 3.87 | 3.27 | 3.16 | 0.00 | |
Total Non-Current Assets | 4.90 | 5.78 | 5.17 | 4.96 | 2.16 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 0.88 | 0.98 | 1.87 | 1.15 | 3.36 | |
Trade Receivables | 47.03 | 49.42 | 44.58 | 37.47 | 40.42 | |
Cash And Cash Equivalents | 0.38 | 0.32 | 0.28 | 0.18 | 1.05 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 2.43 | |
OtherCurrentAssets | 13.02 | 12.25 | 12.32 | 1.10 | 0.00 | |
Total Current Assets | 61.31 | 62.97 | 59.05 | 39.91 | 47.25 | |
Total Assets | 66.20 | 68.75 | 64.22 | 44.87 | 49.41 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.22 | 0.25 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | 14.01 | 15.80 | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 0.43 | 0.43 | 0.43 | 0.38 | 0.38 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y
10.09.2025
Vaishali Pharma Standalone June 2025 Net Sales at Rs 23.75 crore, up 31.35% Y-o-Y
12.06.2025
Vaishali Pharma Standalone March 2025 Net Sales at Rs 32.25 crore, down 0.46% Y-o-Y
26.11.2024
Vaishali Pharma Standalone September 2024 Net Sales at Rs 20.79 crore, up 65.42% Y-o-Y
19.08.2024
Vaishali Pharma Standalone June 2024 Net Sales at Rs 18.08 crore, up 34.7% Y-o-Y